Adage Capital Partners GP »

Rapt Therapeutics shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.3M 275k 33.87

More positions owned by Adage Capital Partners GP

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
ConocoPhillips (COP)
Visa Com Cl A (V)
Johnson & Johnson (JNJ)

View all positions for Adage Capital Partners GP

Top funds holding Rapt Therapeutics

Fcpm Iii Services B.v.
Rtw Investments
Siren
Vanguard Group
Caligan Partners
State Street Corporation
Susquehanna International
FMR
Adage Capital Partners GP
Qube Research & Technologies
Caption Management
Velan Capital Investment Management
Renaissance Technologies
Marshall Wace
Barclays

View all funds holding Rapt Therapeutics